
1. j transplant. 2012 aug;12(8):2172-80. doi: 10.1111/j.1600-6143.2012.04076.x.
epub 2012 apr 30.

prospective analysis human cytomegalovirus dnaemia specific cd8+ cell
responses lung transplant recipients.

weseslindtner l(1), kerschner h, steinacher d, nachbagauer r, kundi m, jaksch p, 
simon b, hatos-agyi l, scheed a, klepetko w, puchhammer-stöckl e.

author information: 
(1)department virology, medical university vienna, vienna, austria.

in lung transplant recipients (lutrs), human cytomegalovirus (hcmv) dnaemia may
be associated hcmv disease reduced survival allograft. 
cells essential controlling hcmv replication, investigated this
prospective study whether kinetics plasma hcmv dna loads lutrs are
associated hcmv-specific cd8+ cell responses, longitudinally
assessed using standardized assay. sixty-seven lutrs monitored 
first year posttransplantation, mean 17 hcmv dna pcr quantifications
and 11.5 cd8+ cell tests performed per patient. hcmv-specific cd8+ cell
responses displayed variable kinetics different patients, differed
significantly onset hcmv dnaemia lutrs subsequently
experienced episodes dnaemia high (>1000 copies/ml) low plasma dna
levels (p = 0.0046, fisher's exact test), absent hcmv disease. in
hcmv-seropositive lutrs, high-level dnaemia requiring preemptive therapy occurred
more frequently hcmv-specific cd8+ cell responses fluctuated, were
detected hcmv dna detection, remained undetectable (p = 0.0392,
fisher's exact test). thus, data indicate hcmv-specific cd8+ cells
influence magnitude hcmv dnaemia episodes, propose a
standardized measurement cd8+ cell immunity might contribute monitoring
the immune status lutrs posttransplantation.

© copyright 2012 american society transplantation american society
of transplant surgeons.

doi: 10.1111/j.1600-6143.2012.04076.x 
pmid: 22548920  [indexed medline]

